Literature DB >> 12827232

Organ-specific response to inhibition of mitochondrial metabolism by cyclosporine in the rat.

Natalie Serkova1, Jost Klawitter, Claus U Niemann.   

Abstract

To evaluate organ-specific metabolic changes after in vivo cyclosporine (CyA) treatment, male Wistar rats were treated with 10 mg/kg per day CyA orally for 6 days. Blood, kidney, liver, and heart tissues were extracted and analyzed by magnetic resonance spectroscopy (MRS). CyA decreased the energy balance [adenosine triphosphate (ATP)/adenosine diphosphate (ADP)] in all organs (kidney [control]: 50%, liver: 64%, and heart: 62%, all P<0.01) due to decreased activity of the mitochondrial Krebs cycle and oxidative phosphorylation. As a compensatory effect, anaerobic glycolysis (lactate) was increased. This was reflected in the low glucose level in the kidney and heart, but not in the liver where a significant decrease in glycogen was seen. Only in the kidney was mitochondrial inhibition accompanied by decreased polyunsaturated fatty acid (PUFA) concentrations and elevated lipid peroxidation. The metabolic marker for nephrotoxicity, trimethylamine-N-oxide (TMAO), was elevated. While CyA decreased mitochondrial homeostasis in all organ systems, cellular adaptation was different and most efficient in the liver.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12827232     DOI: 10.1007/s00147-003-0631-1

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  9 in total

Review 1.  Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management.

Authors:  Yingmei Zhang; Adam T Whaley-Connell; James R Sowers; Jun Ren
Journal:  Pharmacol Ther       Date:  2018-06-22       Impact factor: 12.310

2.  Low-salt diet and cyclosporine nephrotoxicity: changes in kidney cell metabolism.

Authors:  Jelena Klawitter; Jost Klawitter; Volker Schmitz; Nina Brunner; Amanda Crunk; Kyler Corby; Jamie Bendrick-Peart; Dieter Leibfritz; Charles L Edelstein; Joshua M Thurman; Uwe Christians
Journal:  J Proteome Res       Date:  2012-10-11       Impact factor: 4.466

3.  Association of immunosuppressant-induced protein changes in the rat kidney with changes in urine metabolite patterns: a proteo-metabonomic study.

Authors:  Jost Klawitter; Jelena Klawitter; Erich Kushner; Karen Jonscher; Jamie Bendrick-Peart; Dieter Leibfritz; Uwe Christians; Volker Schmitz
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

4.  Toxicodynamic effects of ciclosporin are reflected by metabolite profiles in the urine of healthy individuals after a single dose.

Authors:  Jost Klawitter; Manuel Haschke; Christine Kahle; Colleen Dingmann; Jelena Klawitter; Dieter Leibfritz; Uwe Christians
Journal:  Br J Clin Pharmacol       Date:  2010-08       Impact factor: 4.335

5.  Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors.

Authors:  Uwe Christians; Sven Gottschalk; Jelena Miljus; Carsten Hainz; Leslie Z Benet; Dieter Leibfritz; Natalie Serkova
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

6.  A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy.

Authors:  Weiguo Sui; Liping Li; Wenti Che; Zuo Guimai; Jiejing Chen; Wuxian Li; Yong Dai
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 7.  The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.

Authors:  Xiaoqin Zhang; Ewud Agborbesong; Xiaogang Li
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

Review 8.  The Effect of Polyphenols on Kidney Disease: Targeting Mitochondria.

Authors:  Fatemeh Ashkar; Khushwant S Bhullar; Jianping Wu
Journal:  Nutrients       Date:  2022-07-29       Impact factor: 6.706

9.  Green tea polyphenols stimulate mitochondrial biogenesis and improve renal function after chronic cyclosporin a treatment in rats.

Authors:  Hasibur Rehman; Yasodha Krishnasamy; Khujista Haque; Ronald G Thurman; John J Lemasters; Rick G Schnellmann; Zhi Zhong
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.